Company & Sponsor Intelligence
University of Cambridge
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting1
Completed1
Countries2
Therapeutic footprint
alzheimersautismout_of_scopestroke
Indexed studies
NCT04330222Cambridge 7 Tesla Cerebral Small Vessel Disease Study
stroke · United KingdomUNKNOWN
stroke · United KingdomUNKNOWN
NCT07786116The Role of METhanogens in the PROgression Of Parkinson's Disease and Related Neurological Conditions
alzheimers · United KingdomNA
alzheimers · United KingdomNA
NCT02065193Prevalence of Autism Spectrum Conditions in Mainland China
autism · ChinaUNKNOWN
autism · ChinaUNKNOWN
NCT02498041The Efficacy and Patient Tolerance of Ultrathin Nasal Endoscopy to Detect Barrett's Oesophagus
out_of_scope · NA
out_of_scope · NA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →